Pedicord Donna L, Seiffert Dietmar, Blat Yuval
Department of Chemical Enzymology, Bristol-Myers-Squibb Company, 311 Pennington-Rocky-Hill Road, Pennington, NJ 08534, USA.
Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12855-60. doi: 10.1073/pnas.0705566104. Epub 2007 Jul 25.
In this study, we tested the hypothesis that factor XI (FXI) activation occurs in plasma following activation of the extrinsic pathway by thrombin-mediated feedback activation. We used two different assays: (i) a direct measurement of activated FXI by ELISA and (ii) a functional assay that follows the activation of the coagulation cascade in the presence or absence of a FXI inhibiting antibody by monitoring thrombin activity. We failed to detect any FXI activation or functional contribution to the activation of the coagulation cascade in platelet poor or platelet-rich plasma, when activation was initiated by thrombin or tissue factor. Additionally, we found that, in the absence of a contact system inhibitor during blood draw, contact activation of FXI can mistakenly appear as thrombin- or tissue-factor-dependent activation. Thus, activation of FXI by thrombin in solution or on the surface of activated platelets does not appear to play a significant role in a plasma environment. These results call for reevaluation of the physiological role of the contact activation system in blood coagulation.
在本研究中,我们检验了以下假设:凝血酶介导的反馈激活使外源性途径激活后,血浆中会发生因子 XI(FXI)的激活。我们使用了两种不同的检测方法:(i)通过酶联免疫吸附测定法(ELISA)直接测量活化的 FXI;(ii)一种功能检测方法,通过监测凝血酶活性,在存在或不存在 FXI 抑制抗体的情况下跟踪凝血级联反应的激活。当由凝血酶或组织因子启动激活时,我们未能在乏血小板血浆或富血小板血浆中检测到任何 FXI 激活或其对凝血级联反应激活的功能贡献。此外,我们发现,在采血过程中不存在接触系统抑制剂时,FXI 的接触激活可能会错误地表现为凝血酶或组织因子依赖性激活。因此,溶液中或活化血小板表面的凝血酶对 FXI 的激活似乎在血浆环境中不起重要作用。这些结果要求重新评估接触激活系统在血液凝固中的生理作用。